ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,414 | +146.7% | 40,598 | +179.5% | 0.00% | – |
| Q2 2023 | $33,403 | -47.3% | 14,523 | -30.6% | 0.00% | – |
| Q1 2023 | $63,433 | +19.7% | 20,935 | -8.0% | 0.00% | – |
| Q4 2022 | $53,014 | +20.5% | 22,753 | -0.3% | 0.00% | – |
| Q3 2022 | $44,000 | -17.0% | 22,822 | +17.5% | 0.00% | – |
| Q2 2022 | $53,000 | -8.6% | 19,430 | +2.1% | 0.00% | – |
| Q2 2021 | $58,000 | -42.6% | 19,036 | -32.3% | 0.00% | – |
| Q1 2019 | $101,000 | -78.3% | 28,128 | -76.9% | 0.00% | -100.0% |
| Q4 2018 | $466,000 | +5.9% | 121,642 | +161.2% | 0.00% | – |
| Q3 2018 | $440,000 | +214.3% | 46,576 | +142.3% | 0.00% | – |
| Q2 2018 | $140,000 | – | 19,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |